Finance

Beta
Lists
SENORES:NSE
Senores Pharmaceuticals Ltd
₹1,129.60
+1.46%
(+16.25) 1D
May 29, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SENORES...
Open
₹1,128.90
High
₹1,134.00
Low
₹1,099.80
Mkt. cap
51.61B
Avg. vol.
513.67K
Volume
253.20K
P/E ratio
42.80
52-wk high
₹1,194.40
52-wk low
₹504.05
EPS
₹26.39
No. of employees
194
Open
₹1,128.90
High
₹1,134.00
Low
₹1,099.80
Mkt. cap
51.61B
Avg. vol.
513.67K
Volume
253.20K
P/E ratio
42.80
52-wk high
₹1,194.40
52-wk low
₹504.05
EPS
₹26.39
No. of employees
194
News stories
From sources across the web
About Senores Pharmaceuticals Ltd
CEO-
Employees194
Founded2017
Headquarters-
SectorPharmaceutical industry
Websitesenorespharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.38B
1.53B
1.65B
1.75B
Cost of goods sold
613.60M
570.80M
670.20M
662.20M
Cost of revenue
613.60M
570.80M
670.20M
662.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
216.50M
296.30M
306.60M
303.20M
Operating expense
484.50M
548.70M
517.00M
707.80M
Total operating expenses
1.10B
1.12B
1.19B
1.37B
Operating income
281.80M
414.10M
461.40M
381.90M
Other non operating income
33.50M
54.10M
37.90M
176.70M
EBT including unusual items
264.90M
406.30M
446.00M
474.00M
EBT excluding unusual items
264.90M
406.30M
446.00M
474.00M
Income tax expense
53.10M
105.10M
110.20M
107.30M
Effective tax rate
20.05%
25.87%
24.71%
22.64%
Other operating expenses
208.10M
171.50M
131.80M
311.60M
Net income
197.30M
323.80M
316.60M
316.10M
Net profit margin
14.30%
21.11%
19.20%
18.04%
Earnings per share
-
6.54
7.29
7.96
Interest and investment income
-
-
-
-
Interest expense
-50.40M
-61.90M
-53.30M
-84.60M
Net interest expenses
-50.40M
-61.90M
-53.30M
-84.60M
Depreciation and amortization charges
59.90M
80.90M
78.60M
93.00M
EBITDA
323.90M
484.55M
499.80M
460.02M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer